Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) HKSE

Currency In HKD

AD

Zylox-Tonbridge Medical Technology Co., Ltd.

Address

Building 1

Hangzhou, ZH 311121

China

Phone

86 571 8861 0082

Sector

Healthcare

Industry

Medical - Devices

Employees

875

First IPO Date

July 05, 2021

Key Executives

NameTitlePayYear Born
Zhong ZhaoFounder, Chairman & Chief Executive Officer9.01M1968
Yang XieSenior Vice President of Sales & Marketing and Executive Director5.43M1970
Zheng LiSenior Vice President, GM of Neurovascular Business & Executive Director6.72M1979
Sau In KwanJoint Company Secretary0N/A
Quanwei YuanChief Financial Officer & Joint Company Secretary01980
AD

Description

Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.

AD